DISTREPTAZA IN COMPLEX MANAGEMENT OF CHRONIC BACTERIAL PROSTATITIS
Chronic prostatitis is the most common urological disease worsening the quality of life of modern men and often leads to disorders of the sexual function and fertility. Difficulties in the chronic prostatitis treatment are well known. The traditional therapy schemes include antibiotics, anti-inflammatory remedies, and drugs to improve the microcirculation. Recently, the enzyme drugs with fibrinolytic and proteolytic activities acquire relevance in the treatment of chronic prostatitis. The article presents the results of a prospective open randomized controlled clinical trial of Distreptaza efficacy in management of chronic bacterial prostatitis.